Eledon Pharmaceuticals (ELDN) Other Operating Expenses (2019 - 2025)

Eledon Pharmaceuticals (ELDN) has 4 years of Other Operating Expenses data on file, last reported at -$54.3 million in Q4 2025.

• Quarterly Other Operating Expenses rose 15.21% year-over-year to -$54.3 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$54.3 million (up 15.21% YoY) and the FY2025 annual result came in at $7.5 million, up 111.67% from the prior year.
• Other Operating Expenses improved to -$54.3 million in Q4 2025, from -$64.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $48.6 million in Q4 2022 to a low of -$64.0 million in Q4 2024.
• A 3-year average of -$23.2 million and a median of -$54.3 million in 2025 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 15.21% in 2025, down 15.21% in 2025.
• Tracing ELDN's Other Operating Expenses over 3 years: stood at $48.6 million in 2022, then plunged by 231.63% to -$64.0 million in 2024, then advanced by 15.21% to -$54.3 million in 2025.
• The last three Other Operating Expenses figures came in at -$54.3 million (Q4 2025), -$64.0 million (Q4 2024), and $48.6 million (Q4 2022), per Business Quant data.